Ask A Pharmacist:Ambien CR is approved for long term use but not so for regular Ambien. Please explain the difference.
Ambien: Ambien (zolpidem tartrate) is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. The clinical trials performed in support of efficacy were 4-5 weeks in duration with the final formal assessments of sleep latency performed at the end of treatment. Ambien has been shown to decrease sleep latency for up to 35 days in controlled clinical studies.
Answer: Hello and thank you for your question!
Please explain the difference.
BRIDGEWATER, NJ -- July 12, 2006 -- Sanofi-aventis today announced results from a study that demonstrated Ambien CR (zolpidem tartrate extended release.
Ambien is a drug member of the sedative medication prescribed to treat insomnia. Also known as Zolpidem, Ambien medication is commonly.